The Enterprise Value as of August 2024 (TTM) for Kinnate Biopharma Inc. (KNTE) is 71.17M

According to Kinnate Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.17M. This represents a change of -28.88% compared to the average of 100.07M of the last 4 quarters.

Kinnate Biopharma Inc. (KNTE) Historical Enterprise Value (quarterly & annually)

How has KNTE Enterprise Value performed in the past?

The mean historical Enterprise Value of Kinnate Biopharma Inc. over the last ten years is 725.01M. The current 71.17M Enterprise Value has changed 881.62% with respect to the historical average. Over the past ten years (40 quarters), KNTE's Enterprise Value was at its highest in in the December 2019 quarter at 1.62B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Kinnate Biopharma Inc. (KNTE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kinnate Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kinnate Biopharma Inc. (KNTE) Average Enterprise Value

How has KNTE Enterprise Value performed in the past?

The current Enterprise Value of Kinnate Biopharma Inc. (KNTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kinnate Biopharma Inc. (KNTE) Enterprise Value vs. Peers

How is KNTE’s Enterprise Value compared to its peers?

Kinnate Biopharma Inc.’s Enterprise Value is less than Ambrx Biopharma Inc. (1.56B), less than Acelyrin, Inc. (296.05M), greater than Windtree Therapeutics, Inc. (3.72M), greater than Palisade Bio, Inc. (-6597681.00), less than Century Therapeutics, Inc. (138.60M), greater than Passage Bio, Inc. (44.87M), greater than Homology Medicines, Inc. (-103303255.00), less than Generation Bio Co. (210.95M), less than Stoke Therapeutics, Inc. (586.20M), less than Gracell Biotechnologies Inc. (5.45B), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (284.72M), less than Design Therapeutics, Inc. (221.42M), less than Erasca, Inc. (689.13M), greater than Kronos Bio, Inc. (16.29M), less than C4 Therapeutics, Inc. (369.73M), less than Edgewise Therapeutics, Inc. (1.60B), greater than Surrozen, Inc. (-6000669.00), greater than Bolt Biotherapeutics, Inc. (37.47M), less than Larimar Therapeutics, Inc. (486.93M), less than Keros Therapeutics, Inc. (1.58B), greater than Kezar Life Sciences, Inc. (30.16M),

Build a custom stock screener for Kinnate Biopharma Inc. (KNTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kinnate Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kinnate Biopharma Inc. (KNTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kinnate Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.